Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJ. Karbwangen_US
dc.contributor.authorK. Na Bangchangen_US
dc.contributor.authorA. Thanavibulen_US
dc.contributor.authorD. Bunnagen_US
dc.contributor.authorT. Chongsuphajaisiddhien_US
dc.contributor.authorT. Harinasutaen_US
dc.contributor.otherMahidol Universityen_US
dc.identifier.citationThe Lancet. Vol.340, No.8830 (1992), 1245-1248en_US
dc.description.abstractPlasmodium falciparum malaria in Thailand is highly resistant to available antimalarials, and alternative drugs are needed urgently. Artemether is effective against falciparum malaria but associated with a high recrudescence rate. The proper dosage regimen remains to be defined. We have done a clinical trial comparing mefloquine 1250 mg in divided doses with oral artemether at 700 mg total dose given over 5 days in acute uncomplicated falciparum malaria. 46 patients, admitted to the Bangkok Hospital for Tropical Diseases, were randomised to receive either mefloquine (12) or artemether (34). Hospital follow-up was 28 days for the artemether group and 42 days for the mefloquine group. Oral artemether gave a significantly faster parasite clearance time than mefloquine (30 vs 64 h), and a significantly better cure rate (97 vs 64%) with fewer episodes of dizziness and vomiting. Oral artemether at 700 mg given over 5 days is effective and well tolerated. The cure rate with this regimen is higher than that reported by previous studies with 600 mg intramuscular artemether given over 5 days. Oral artemether can be considered as an alternative drug for multiple-drug-resistant falciparum malaria. © 1992.en_US
dc.rightsMahidol Universityen_US
dc.titleComparison of oral artemether and mefloquine in acute uncomplicated falciparum malariaen_US
Appears in Collections:Scopus 1991-2000

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.